Pay in 4 interest-free payments of $6.35 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
2016 Aug 19;17(8):1359
Interestingly, fusion of GRX1 to the N-termini of different roGFP variants consistently leads to a slight shift of 513 mV in the midpoint potentials toward more negative values
For example, in T-lymphoblastic leukemia cells, inhibition of mammalian target of rapamycin (mTOR) signaling downregulates G6PD, resulting in excess ROS and cell death (64)
In contrast, modified NADs typically require carriers to enter target cells and reach specific intracellular locations
They accomplish this by binding to specific receptors on cell surfaces and activating biological pathways that stimulate tissue repair, reduce inflammation, and improve circulation to injured areas
US$ 23.91
US$ 29.23
US$ 26.90
US$ 28.24
US$ 29.77
